National Leading Research Laboratory of Clinical Nutrigenetics/Nutrigenomics, Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul, Korea.
Department of Internal Medicine, Severance Hospital, Division of Endocrinology and Metabolism, Yonsei University College of Medicine, Seoul, Korea.
J Am Coll Nutr. 2020 Mar-Apr;39(3):206-215. doi: 10.1080/07315724.2019.1635052. Epub 2019 Aug 1.
: The aim of the study is to investigate the effect of Jeju steamed onion (ONIRO) on body fat and metabolic profiles in overweight subjects. This randomized, double-blind, placebo-controlled clinical intervention was conducted and completed at one clinical research site. The subjects ( = 70) were randomly divided into placebo or test group and were instructed to take before each meal either the placebo or ONIRO capsule for 12 weeks. Anthropometric as well as serum and metabolic parameters, including triglycerides, cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, leptin, adiponectin, C-peptide, and aspartate aminotransferase (AST) were measured at baseline and after 12 weeks. Body composition was also measured by dual-energy x-ray absorptiometry (DEXA) and computed tomography (CT). This trial is registered under the trial registration code clinicaltrials.gov: NCT03645382 (https://register.clinicaltrials.gov). Compared to the placebo, ONIRO supplementation for significantly reduced the percentage of body fat and fat mass as measured by DEXA ( = 0.028 and 0.022, respectively) with no significant effects on lean body mass. CT analyses at the L1 level showed a significant decrease in the areas of whole fat, visceral fat, and subcutaneous fat ( = 0.009, = 0.039, = 0.020, respectively), while CT scan of L4 resulted in a significant reduction of whole fat area and subcutaneous area ( = 0.006 and = 0.012, respectively). The levels of triglycerides (TG) and C-peptide were significantly lower after 12 weeks of ONIRO treatment. These findings suggest that ONIRO supplementation reduces total body fat, notably abdominal visceral fat, with positive changes of the clinically relevant metabolic parameters serum TG and C-peptide.
: 本研究旨在探讨济州蒸洋葱(ONIRO)对超重受试者体脂肪和代谢特征的影响。这是一项随机、双盲、安慰剂对照的临床干预研究,在一个临床研究地点进行并完成。受试者(n=70)被随机分为安慰剂组或试验组,并被指示在每餐饭前服用安慰剂或 ONIRO 胶囊,持续 12 周。在基线和 12 周后测量了人体测量学以及血清和代谢参数,包括甘油三酯、胆固醇、低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇、瘦素、脂联素、C 肽和天门冬氨酸氨基转移酶(AST)。身体成分也通过双能 X 射线吸收法(DEXA)和计算机断层扫描(CT)进行测量。这项试验在临床试验.gov 注册号为 NCT03645382(https://register.clinicaltrials.gov)下进行了注册。与安慰剂相比,ONIRO 补充剂可显著降低 DEXA 测量的体脂肪和脂肪质量的百分比(分别为 0.028 和 0.022),而对瘦体重没有显著影响。L1 水平的 CT 分析显示,全脂肪、内脏脂肪和皮下脂肪的面积均显著减少(分别为 0.009、0.039 和 0.020),而 L4 的 CT 扫描则导致全脂肪面积和皮下脂肪面积显著减少(分别为 0.006 和 0.012)。ONIRO 治疗 12 周后,甘油三酯(TG)和 C 肽水平显著降低。这些发现表明,ONIRO 补充剂可减少全身脂肪,特别是腹部内脏脂肪,同时改善与临床相关的代谢参数血清 TG 和 C 肽。